HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

Latest Conference Articles

The HCPLive conference coverage page features articles, videos, and expert-led live coverage from major medical meetings throughout the year.

Patients With Vitiligo Report Varied Severe Symptoms Based on Skin Tone

Patients With Vitiligo Report Varied Severe Symptoms Based on Skin Tone

September 8th 2022, 8:11pm

Large numbers of vitiligo patients around the world have reported differing outcomes, with darker skin types expressing the more significant severity, according to new findings.

Ruxolitinib Beneficial Across Demographics of Patients with Vitiligo

Ruxolitinib Beneficial Across Demographics of Patients with Vitiligo

September 8th 2022, 7:45pm

Research presented at EADV 2022 sees positive outcomes with the targeted therapy for patients of varied backgrounds with vitiligo.

Promising Data from InPedILD Phase 3 Trial Revealed at ERS Congress 2022

Promising Data from InPedILD Phase 3 Trial Revealed at ERS Congress 2022

September 8th 2022, 4:02pm

Novel insights into the risk-benefit profile of nintedanib in children and adolescents with fibrosing interstitial lung disease (ILD) were provided by late-breaking data presented at ERS 2022 regarding the InPedILD clinical trial.

ERS Data Support Web-Based Management to Increase Physical Activity in COPD Population

ERS Data Support Web-Based Management to Increase Physical Activity in COPD Population

September 7th 2022, 6:00pm

These data support web-based self-management for individuals with COPD with an objective, clinically relevant, short-term increase in physical activity levels compared to usual care.

Phase 2b Study Supports Icenticaftor for Patients with COPD, Chronic Bronchitis

Phase 2b Study Supports Icenticaftor for Patients with COPD, Chronic Bronchitis

September 6th 2022, 9:00pm

“From this study it makes sense that the (icenticaftor) 300mg dose has a benefit-risk profile to further study the clinical benefits,” Dr. Frits Franssen, lead investigator, said at ERS Congress 2022.

Rising Temperatures Detrimental to Renal Function in Heart Failure Outpatients

Rising Temperatures Detrimental to Renal Function in Heart Failure Outpatients

August 31st 2022, 1:00pm

Temperatures changes between summer and the rest of the year correlated with the magnitude of decrease in renal function during summer.

Fish Oil Supplement Intake Influences Long-Term Atrial Fibrillation Risk

Fish Oil Supplement Intake Influences Long-Term Atrial Fibrillation Risk

August 30th 2022, 4:00pm

Increased risk of AF by fish oil supplement was found to be prominent in low­ risk participants with healthy lifestyles.

Full-Dose Anticoagulation Lowers Thrombotic Event Risk in Patients with COVID-19

Full-Dose Anticoagulation Lowers Thrombotic Event Risk in Patients with COVID-19

August 29th 2022, 10:00pm

Full-dose anticoagulation, but not clopidogrel, reduced thrombotic complications in critically-ill patients with COVID-19.

Atrial Fibrillation Screening Using Smartphones Significantly Increases Detection Rate

Atrial Fibrillation Screening Using Smartphones Significantly Increases Detection Rate

August 29th 2022, 8:00pm

Digital screening more than doubled the detection rate of treatment-relevant AF in both phases of eBRAVE-AF trial.

Blood Pressure Targets Show No Benefit in Comatose Survivors of Cardiac Arrest

Blood Pressure Targets Show No Benefit in Comatose Survivors of Cardiac Arrest

August 28th 2022, 1:00pm

Targeting a mean arterial blood pressure of 77 mm Hg or 63 mm Hg was not associated with significantly different percentages of patients dying or having severe disability or coma.